Both in Pharmaceuticals
Equillium vs Perspective Therapeutics
Over the past year EQ returned −9.0% and CATX returned −66.2%; their daily moves had a correlation of 0.19.
EQ −9.0% CATX −66.2%Growth of $1, one year, split-adjusted
| Metric | EQ | CATX |
|---|---|---|
| Price | $1.41 | $0.8800 |
| Market cap | $110.5M | $100.5M |
| Today | +2.17% | −15.38% |
| 1 month | −2.8% | −65.8% |
| 6 months | −31.9% | −75.9% |
| Year to date | −9.0% | −68.0% |
| 1 year | 0.0% | −67.8% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 245.6× |
| Net cash | $57.2M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 89.8% | 118.2% |
| Short % of float | 12.6% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).